|
Delphi VenturesAlder Biopharmaceuticals Gets $40M Series C FinancingAlder Biopharmaceuticals, Inc., an antibody therapeutics startup, today announced the its Series C financing. Delphi Ventures and TPG Biotech led the $40 million round. Also participating in the round more... Discuss | | by Jitendra 325 days ago (biospace.com)Evalve pulls in $60M, heats up heart-valve implant raceInvestors including BBT Fund, Delphi Ventures, New Enterprise Associates, Split Rock Partners and Abbott Laboratories have pumped in $60 Million into this fourth round of funding for this Menlo Park based more... Discuss | | by Jitendra 367 days ago (venturebeat.com)« previous1 next » |
|